Switch to:
More From Other Websites
ChemoCentryx to Hold Third Quarter 2014 Financial Results Conference Call on Wednesday, November 5,... Oct 22 2014
ChemoCentryx to Hold Third Quarter 2014 Financial Results Conference Call on Wednesday, November 5,... Oct 22 2014
ChemoCentryx's Orally Administered CCR9 Inhibitor, CCX507, Shown to be Well Tolerated and Effective... Oct 21 2014
ChemoCentryx's Orally Administered CCR9 Inhibitor, CCX507, Shown to be Well Tolerated and Effective... Oct 21 2014
ChemoCentryx Releases Phase III SHIELD 4 Clinical Results in Patients With Crohn's Disease Oct 20 2014
ChemoCentryx Releases Phase III SHIELD 4 Clinical Results in Patients With Crohn's Disease Oct 20 2014
ChemoCentryx, Inc. (CCXI) in Focus: Stock Rises 9.6% Oct 17 2014
ChemoCentryx Appoints Israel F. Charo, M.D., Ph.D., Senior Vice President of Research Sep 22 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK